Serum Na <135 mEq/L; evaluated by volume status and urine osmolality/sodium.
Also known as: hyponatremia, low sodium, SIADH
Overview
Serum sodium concentration <135 mEq/L. Classified by severity (mild 130-134, moderate 125-129, severe <125), acuity (acute <48 h vs chronic), tonicity (hypotonic — true hyponatremia — vs isotonic vs hypertonic pseudohyponatremia), and volume status (hypovolemic, euvolemic, hypervolemic).
Epidemiology
Most common electrolyte abnormality in hospitalized patients (~15-20%). Associated with increased morbidity, mortality, and length of stay across populations.
Try two board-style Hyponatremia questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1RenalMedium
A 65-year-old male with small cell lung cancer has serum sodium 118, urine osmolality 450, urine sodium 60, normal volume status, normal thyroid and adrenal function. Which of the following is the most likely diagnosis?
ACerebral salt wasting from BNP excess
BPrimary polydipsia from excess thirst
CLow-solute hyponatremia from poor intake
DDiabetes insipidus from ADH deficiency
ESIADH from ectopic ADH secretion
Reveal answer & full explanation
Correct answer: E — SIADH from ectopic ADH secretion
ACerebral salt wasting from BNP excess
BPrimary polydipsia from excess thirst
CLow-solute hyponatremia from poor intake
DDiabetes insipidus from ADH deficiency
ESIADH from ectopic ADH secretion✓
Why SIADH from ectopic ADH secretion is correct
Small cell lung cancer is the most classic cause of ectopic antidiuretic hormone (ADH) secretion, producing syndrome of inappropriate antidiuretic hormone secretion (SIADH).
SIADH causes free water retention and euvolemic hyponatremia.
Classic lab findings: hyponatremia, inappropriately concentrated urine (osmolality >100, often >300), urine Na >40, normal volume status, and normal thyroid and adrenal function, all present in this patient; low blood urea nitrogen (BUN) and low uric acid are also typical.
Why the others are wrong
Diabetes insipidus from ADH deficiency — causes hypernatremia and dilute urine (low urine osmolality) from inability to concentrate urine; opposite of this presentation.
Cerebral salt wasting from BNP excess — renal salt loss after intracranial disease, attributed to brain natriuretic peptide (BNP) release, also causes hyponatremia and high urine sodium but is associated with hypovolemia, not euvolemia, and follows CNS injury, not lung cancer.
Primary polydipsia from excess thirst — excess water intake can lower serum sodium, but ADH stays appropriately suppressed, so the urine is maximally dilute (osmolality under 100 mOsm/kg); this patient's urine osmolality of 450 reflects inappropriate ADH activity instead.
Low-solute hyponatremia from poor intake — anorexia and poor oral intake are common in cancer, and a tea-and-toast pattern of scant solute intake does cause euvolemic hyponatremia, but ADH is appropriately suppressed and free-water excretion is capped only by the low solute load, so the urine is maximally dilute with a low urine sodium; this patient's urine osmolality of 450 and urine sodium of 60 reflect inappropriate ADH activity instead.
Treatment hierarchy: fluid restriction (first-line), salt tabs, loop diuretic, hypertonic saline if severe.
Correct slowly to avoid osmotic demyelination: maximum 8 mEq/L per 24 hours.
Tolvaptan (V2 antagonist) for refractory SIADH.
Question 2RenalMedium
A 62-year-old man with small cell lung cancer is euvolemic with sodium 119 mEq/L, low serum osmolality, high urine osmolality, and high urine sodium. He is confused. Which of the following is the most appropriate treatment?
AOral tolvaptan 15 mg once daily
BFluid restriction to under 1 L daily
CHypertonic saline with close monitoring
DIsotonic 0.9% saline at 100 mL per hour
EDesmopressin acetate 2 mcg intravenously
Reveal answer & full explanation
Correct answer: C — Hypertonic saline with close monitoring
AOral tolvaptan 15 mg once daily
BFluid restriction to under 1 L daily
CHypertonic saline with close monitoring✓
DIsotonic 0.9% saline at 100 mL per hour
EDesmopressin acetate 2 mcg intravenously
Why Hypertonic saline with close monitoring is correct
Symptomatic hyponatremia at 119 mEq/L with confusion warrants 3% hypertonic saline to lift the sodium enough to relieve cerebral edema.
The pattern (euvolemic, low serum osmolality, inappropriately concentrated urine, urine sodium high) is SIADH from ectopic ADH by small cell lung cancer.
Close monitoring caps the rise at roughly 6-8 mEq/L per 24 hours to prevent osmotic demyelination.
Why the others are wrong
Fluid restriction to under 1 L daily — Too-slow trap: fluid restriction is first-line for mild or asymptomatic SIADH, but it raises the sodium over days, too slowly for a patient who is already confused, and a urine osmolality above about 500 mOsm/kg predicts it will fail.
Isotonic 0.9% saline at 100 mL per hour — Isotonic trap: in SIADH the kidney excretes the infused sodium in a small volume of concentrated urine and retains the water, so normal saline can push the sodium even lower; isotonic saline treats hypovolemic, not euvolemic, hyponatremia.
Desmopressin acetate 2 mcg intravenously — Buzzword-reversal trap: desmopressin is an ADH analog that further concentrates urine and deepens the hyponatremia.
Oral tolvaptan 15 mg once daily — mechanism-match trap: a V2-receptor antagonist blocks the ectopic ADH driving SIADH and is used for chronic euvolemic hyponatremia, but it is not indicated when neurologic symptoms require an urgent, controlled rise in sodium, and its effect is harder to titrate; confusion at 119 mEq/L calls for hypertonic saline.
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyponatremia outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Exercise-associated hyponatremia (marathon runners over-hydrating with hypotonic fluids)
Desmopressin (DDAVP) for DI, nocturnal enuresis, or bleeding disorders, especially with high fluid intake (e.g., continued into the antidiuretic phase after pituitary surgery)
Pathophysiology
True hypotonic hyponatremia results from excess water relative to sodium. ADH-driven water retention exceeds urinary water excretion capacity. Causes are categorized by volume status: hypovolemic (volume loss replaced with hypotonic fluid), euvolemic (SIADH, hypothyroid, adrenal insufficiency), hypervolemic (HF, cirrhosis, CKD/nephrotic — total body Na increased but water more so). Pseudohyponatremia: severe hyperlipidemia or hyperproteinemia causes lab artifact with normal plasma water Na.
Pseudohyponatremia — Severe hyperlipidemia, hyperproteinemia (multiple myeloma); normal measured osmolality
Translocational hyponatremia — Hyperglycemia, mannitol; correct Na = measured Na + 1.6 × ((glucose - 100)/100)
Cerebral salt wasting — After SAH, neurosurgery, or other acute CNS injury; high urine Na and concentrated urine like SIADH, but truly hypovolemic (orthostasis, negative fluid balance); treat with isotonic or hypertonic saline, not fluid restriction
Diagnostic workup
Diagnostic criteria
Serum Na <135 + serum osm <275 = true hypotonic hyponatremia. Etiology determined by volume status + urine osmolality + urine Na (algorithmic approach).
Labs
Confirm true hypotonic hyponatremia: measure serum osmolality (low <275 mOsm/kg in true; normal in pseudohyponatremia; high in hyperglycemia or mannitol)
TSH, cortisol (or cosyntropin stimulation) to rule out hypothyroidism and adrenal insufficiency
BMP for renal function, glucose; uric acid (low in SIADH and also low in cerebral salt wasting, so volume status, not uric acid, separates them)
Imaging
Chest CT if SIADH suspected to evaluate for malignancy (especially small cell lung)
Brain MRI if CNS process suspected as cause
Diagnostic algorithm
flowchart TD
A[Serum Na <135] --> B[Serum osmolality]
B -->|Normal/High| C[Pseudohyponatremia<br/>or hyperglycemia/mannitol]
B -->|Low <275| D[True hypotonic<br/>hyponatremia]
D --> E[Assess volume status]
E -->|Hypovolemic| F[Urine Na]
F -->|<20| G[Extrarenal loss<br/>GI, skin, blood]
F -->|>40| H[Renal loss<br/>diuretic, adrenal insuff]
E -->|Euvolemic| I[Urine osm]
I -->|<100| J[Primary polydipsia<br/>low solute]
I -->|>100| K[SIADH, hypothyroid,<br/>adrenal insuff]
E -->|Hypervolemic| L[HF, cirrhosis,<br/>nephrotic, CKD]
Diagnostic algorithm for hyponatremia — serum osmolality, then volume status, then urine studies.
Treatment
First-line
Severe symptomatic (seizures, coma, focal neuro deficits):
3% hypertonic saline 100 mL IV bolus, may repeat × 2 every 10 min until symptoms improve; goal is +4-6 mEq/L rise to relieve symptoms
Maximum correction 8-10 mEq/L per 24 h (some experts allow up to 12 mEq/L); slower in chronic, malnourished, alcoholic, or hypokalemic patients to avoid osmotic demyelination
Treat underlying cause once stable
Hypovolemic hyponatremia: isotonic saline (normal saline or lactated Ringer's)
Euvolemic hyponatremia (SIADH): fluid restriction (<800-1000 mL/day) first-line; salt tablets or urea if persistent
Vasopressin receptor antagonists (vaptans): tolvaptan (oral), conivaptan (IV) — for refractory SIADH or hypervolemic hyponatremia; start in hospital and monitor closely due to risk of rapid correction; tolvaptan is limited to 30 days and avoided in liver disease including cirrhosis (hepatotoxicity)
Demeclocycline (induces nephrogenic DI) — historical SIADH therapy, rarely used now
If overcorrection occurs (Na rises >10-12 mEq/L in 24 h): re-lower with D5W ± DDAVP to prevent osmotic demyelination
Complications
Osmotic demyelination syndrome (formerly central pontine myelinolysis) — from overly rapid correction; presents days later with dysarthria, dysphagia, paraparesis, locked-in syndrome; irreversible
Cerebral edema and herniation from severe acute hyponatremia
Seizures
Falls and fractures (chronic mild hyponatremia)
Increased mortality in hospitalized patients
PANCE pearls
First step in hyponatremia evaluation: check serum osmolality. Low (<275) = true hypotonic; normal = pseudohyponatremia; high = translocational (hyperglycemia, mannitol).
SIADH diagnostic criteria: hypotonic hyponatremia + euvolemia + urine osm >100 + urine Na >40 + normal thyroid and adrenal function + no diuretics.
Correct chronic hyponatremia SLOWLY: max 8-10 mEq/L per 24 hours to avoid osmotic demyelination syndrome. Higher-risk patients (alcoholics, malnourished, hypokalemic): even more cautious.
Acute symptomatic hyponatremia (<48 h): 3% hypertonic saline is appropriate emergency treatment regardless of chronicity concerns.
Pseudohyponatremia clue: normal serum osmolality despite low measured Na (lab artifact from hypertriglyceridemia, hyperproteinemia).
Hyperglycemia correction formula: corrected Na = measured Na + 1.6 × ((glucose − 100)/100). Each 100 mg/dL glucose rise lowers Na ~1.6 mEq/L.
Isotonic (0.9%) saline can lower the sodium further in SIADH, especially when urine osmolality is high (above roughly 500 mOsm/kg), because the salt is excreted in a small volume of concentrated urine and the water is retained; use fluid restriction, or 3% saline for moderately severe or severe symptoms such as confusion or seizures.
References
European Society 2014 — Clinical practice guideline on diagnosis and treatment of hyponatraemia (Spasovski et al., Eur J Endocrinol 2014)
Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)
Practice Renal/Urology questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.